ACE Meeting. November 5, 2026. 10:00am PT, 1:00pm ET. Social media offers advocates opportunities to share their experiences, connect with their communities, and bring greater visibility to the issues they care about. This presentation will explore practical strategies for using social media to support advocacy, communicate authentically, and amplify the voices of patients, survivors, caregivers,…
ACE Meeting. September 17, 2026. 1:00pm ET, 10:00am PT). This session will describe the development, evaluation, and global implementation of the Stronger Together peer support program. Drawing on experiences from Viet Nam, Rwanda, Ethiopia, Tanzania and ongoing expansion to the United States and Colombia, and Malaysia, it will explore building academic and clinical partnerships, securing…
ACE Meeting. September 22, 2026. 6:00pm ET, 3:00pm PT. In Hidalgo County, Texas — a community that is 92% Hispanic and carries the highest uninsured rate of any county in the nation — prostate cancer patients face compounding barriers to early detection and support. Drawing on Texas Cancer Registry data, regional screening statistics, and firsthand…
ACE Meeting. August 25, 2026. 3:00pm PT, 6:00pm ET. A cancer diagnosis often leads patients to explore every available option to improve their health, manage symptoms, and enhance their quality of life. As patients navigate complex decisions alongside conventional treatments such as surgery, chemotherapy, radiation, and immunotherapy, advocacy plays an essential role in helping individuals access…
ACE Meeting. August 18, 2026. 3:00pm ET, 12:00pm PT. Advocates often want to connect with cancer researchers at a nearby university, but they may not know who to contact or how to get started. Bob Riter spent twelve years nurturing connections between researchers – mostly in the basic sciences – at Cornell University and individuals…
ACE Meeting. September 29, 2026. 3:00-4:00pm PT, 6:00-7:00pm ET. Cancer trials are only useful to patients if they compare a new treatment against a current and meaningful standard of care. This presentation will explain, in plain language, why control arms matter, how changing treatment standards can affect trial results, and why sometimes the standard of…